company background image
CRW

CranewareAIM:CRW Stock Report

Market Cap

UK£813.6m

7D

-2.1%

1Y

48.4%

Updated

26 Oct, 2021

Data

Company Financials +
CRW fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance1/6
Financial Health6/6
Dividends4/6

CRW Overview

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States.

Craneware Competitors

EMIS Group

AIM:EMIS

UK£853.9m

Softcat

LSE:SCT

UK£4.0b

Kainos Group

LSE:KNOS

UK£2.5b

Health Catalyst

NasdaqGS:HCAT

US$2.6b

Price History & Performance

Summary of all time highs, changes and price drops for Craneware
Historical stock prices
Current Share PriceUK£23.00
52 Week HighUK£15.00
52 Week LowUK£28.30
Beta1.06
1 Month Change0%
3 Month Change4.55%
1 Year Change48.39%
3 Year Change-18.58%
5 Year Change86.61%
Change since IPO1,525.44%

Recent News & Updates

Sep 16
Here's Why I Think Craneware (LON:CRW) Is An Interesting Stock

Here's Why I Think Craneware (LON:CRW) Is An Interesting Stock

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

May 14
Here's Why I Think Craneware (LON:CRW) Is An Interesting Stock

Here's Why I Think Craneware (LON:CRW) Is An Interesting Stock

It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...

Shareholder Returns

CRWGB Healthcare ServicesGB Market
7D-2.1%-1.6%0.2%
1Y48.4%42.0%24.7%

Return vs Industry: CRW exceeded the UK Healthcare Services industry which returned 42.5% over the past year.

Return vs Market: CRW exceeded the UK Market which returned 23.2% over the past year.

Price Volatility

Is CRW's price volatile compared to industry and market?
CRW volatility
CRW Beta1.06
Industry Beta1.02
Market Beta1

Stable Share Price: CRW is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: CRW's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999370Keith Neilsonhttps://public.craneware.com

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits.

Craneware Fundamentals Summary

How do Craneware's earnings and revenue compare to its market cap?
CRW fundamental statistics
Market CapUS$1.12b
Earnings (TTM)US$12.91m
Revenue (TTM)US$75.58m

87.3x

P/E Ratio

14.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
CRW income statement (TTM)
RevenueUS$75.58m
Cost of RevenueUS$5.37m
Gross ProfitUS$70.21m
ExpensesUS$57.30m
EarningsUS$12.91m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.36
Gross Margin92.89%
Net Profit Margin17.08%
Debt/Equity Ratio0%

How did CRW perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

79%

Payout Ratio

Does CRW pay a reliable dividends?

See CRW dividend history and benchmarks

Valuation

Is Craneware undervalued compared to its fair value and its price relative to the market?

87.28x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CRW (£22.9) is trading above our estimate of fair value (£7.4)

Significantly Below Fair Value: CRW is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CRW is poor value based on its PE Ratio (86.8x) compared to the European Healthcare Services industry average (56.7x).

PE vs Market: CRW is poor value based on its PE Ratio (86.8x) compared to the UK market (21.3x).


Price to Earnings Growth Ratio

PEG Ratio: CRW is poor value based on its PEG Ratio (3.4x)


Price to Book Ratio

PB vs Industry: CRW's PB Ratio (4.3x) is in line with the GB Healthcare Services industry average.


Future Growth

How is Craneware forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

25.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CRW's forecast earnings growth (25.6% per year) is above the savings rate (0.9%).

Earnings vs Market: CRW's earnings (25.6% per year) are forecast to grow faster than the UK market (12.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CRW's revenue (22% per year) is forecast to grow faster than the UK market (5% per year).

High Growth Revenue: CRW's revenue (22% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CRW's Return on Equity is forecast to be low in 3 years time (9.5%).


Past Performance

How has Craneware performed over the past 5 years?

5.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CRW has a large one-off loss of $6.5M impacting its June 30 2021 financial results.

Growing Profit Margin: CRW's current net profit margins (17.1%) are lower than last year (23.5%).


Past Earnings Growth Analysis

Earnings Trend: CRW's earnings have grown by 5.9% per year over the past 5 years.

Accelerating Growth: CRW's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CRW had negative earnings growth (-23.3%) over the past year, making it difficult to compare to the Healthcare Services industry average (35.8%).


Return on Equity

High ROE: CRW's Return on Equity (5%) is considered low.


Financial Health

How is Craneware's financial position?


Financial Position Analysis

Short Term Liabilities: CRW's short term assets ($255.1M) exceed its short term liabilities ($49.4M).

Long Term Liabilities: CRW's short term assets ($255.1M) exceed its long term liabilities ($1.9M).


Debt to Equity History and Analysis

Debt Level: CRW is debt free.

Reducing Debt: CRW has not had any debt for past 5 years.

Debt Coverage: CRW has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: CRW has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Craneware current dividend yield, its reliability and sustainability?

1.19%

Current Dividend Yield


Upcoming Dividend Payment

TodayOct 26 2021Ex Dividend DateNov 25 2021Dividend Pay DateDec 21 202126 days from Ex DividendBuy in the next 29 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: CRW's dividend (1.2%) isn’t notable compared to the bottom 25% of dividend payers in the UK market (1.4%).

High Dividend: CRW's dividend (1.2%) is low compared to the top 25% of dividend payers in the UK market (4.06%).


Stability and Growth of Payments

Stable Dividend: CRW's dividends per share have been stable in the past 10 years.

Growing Dividend: CRW's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: At its current payout ratio (78.5%), CRW's payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CRW's dividends in 3 years are forecast to be well covered by earnings (48.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.8yrs

Average management tenure


CEO

Keith Neilson (52 yo)

22.75yrs

Tenure

US$465,535

Compensation

Mr. Keith Neilson co-founded Craneware PLC in 1999 and has served as its Chief Executive Officer ever since. Keith’s direction has helped Craneware to win multiple prestigious awards in such areas as inter...


CEO Compensation Analysis

Compensation vs Market: Keith's total compensation ($USD465.54K) is below average for companies of similar size in the UK market ($USD993.37K).

Compensation vs Earnings: Keith's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: CRW's management team is seasoned and experienced (10.8 years average tenure).


Board Members

Experienced Board: CRW's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CRW insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.3%.


Top Shareholders

Company Information

Craneware plc's employee growth, exchange listings and data sources


Key Information

  • Name: Craneware plc
  • Ticker: CRW
  • Exchange: AIM
  • Founded: 1999
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: UK£813.558m
  • Shares outstanding: 35.53m
  • Website: https://public.craneware.com

Number of Employees


Location

  • Craneware plc
  • 1 Tanfield
  • Edinburgh
  • EH3 5DA
  • United Kingdom

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/26 17:48
End of Day Share Price2021/10/26 00:00
Earnings2021/06/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.